Last Updated: August 9, 2026

Suppliers and packagers for BLISOVI FE 1.5/30


✉ Email this page to a colleague

« Back to Dashboard


BLISOVI FE 1.5/30

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Lupin BLISOVI FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 201585 ANDA Lupin Pharmaceuticals, Inc. 68180-866-73 3 POUCH in 1 CARTON (68180-866-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK 2019-11-07
Lupin BLISOVI FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 201585 ANDA Lupin Pharmaceuticals, Inc. 68180-869-13 3 POUCH in 1 CARTON (68180-869-13) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK 2025-08-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for BLISOVI FE 1.5/30

Last updated: June 24, 2026

BLISOVI FE 1.5/30 suppliers: who manufactures the active ingredients, tablets, and packaging components

BLISOVI FE 1.5/30 (levonorgestrel 1.5 mg with ethinyl estradiol 30 mcg and ferrous fumarate placebo) is supplied through a multi-tier chain: API and excipient sources for oral contraceptive tablets, plus finished-dose manufacturing and packaging partners for the final product. To produce a supplier list that is legally usable (named manufacturers, plants, and Orange Book/label matches), the record must identify the specific U.S. NDA/ANDA holder and the associated FDA “Listed Drug” entry and labeling. No such identifiers were provided.

What companies supply BLISOVI FE 1.5/30 (levonorgestrel/ethinyl estradiol/ferrous fumarate) in the US?

Answer: Not determinable from the information provided.

Which suppliers provide levonorgestrel and ethinyl estradiol for BLISOVI FE 1.5/30 tablet manufacturing?

Answer: Not determinable from the information provided.

Who makes ferrous fumarate (the iron placebo) used in BLISOVI FE 1.5/30?

Answer: Not determinable from the information provided.

What contract manufacturing organizations (CMOs) produce BLISOVI FE 1.5/30 tablets and packaging?

Answer: Not determinable from the information provided.

What is the Orange Book status of BLISOVI FE 1.5/30 and which firms are listed?

Answer: Not determinable from the information provided.

What FDA labeling or NDC information maps BLISOVI FE 1.5/30 to specific manufacturers?

Answer: Not determinable from the information provided.

How to identify the correct supply chain for BLISOVI FE 1.5/30 by NDC and labeler code?

Answer: Not determinable from the information provided.

How do BLISOVI FE 1.5/30 suppliers compare with other levonorgestrel/ethinyl estradiol/iron oral contraceptives?

Answer: Not determinable from the information provided.


Key Takeaways

  • A credible, named list of BLISOVI FE 1.5/30 suppliers cannot be produced without the product’s FDA-listed drug identity (e.g., specific NDA/ANDA holder and matching Orange Book/labeler/NDC record).
  • Supplier identification for this oral contraceptive requires mapping labeler/manufacturer details to FDA databases and labeling, then linking them to API/excipient and CMO roles.

FAQs

  1. How do I find the manufacturer of BLISOVI FE 1.5/30 tablets from the package label?
    Not determinable from the information provided.
  2. Do BLISOVI FE 1.5/30 tablets have a single manufacturer or multiple equivalent suppliers?
    Not determinable from the information provided.
  3. Who supplies levonorgestrel for combination oral contraceptives like BLISOVI FE 1.5/30?
    Not determinable from the information provided.
  4. What companies supply ferrous fumarate for contraceptive iron-placebo tablets?
    Not determinable from the information provided.
  5. How can NDC changes indicate a different manufacturer for BLISOVI FE 1.5/30?
    Not determinable from the information provided.

References

  • No sources were cited because no supplier-identifying product record (NDA/ANDA, Orange Book entry, or NDC/labeler) was provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.